Showing results (1141-1150 of 1,162) with videos related to

Sort By:
Pageof 117
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1997
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal InfectionsJ E Edwards, G P Bodey, R A Bowden, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
Mild HIV-specific selective forces overlaying natural CD4+ T cell dynamics explain the clonality and decay dynamics of HIV reservoir cellsDaniel B Reeves, Danielle N Rigau, Arianna Romero, et al.
Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Depression associated with incident Type I MI among people with HIVEmily P Hyle, Elizabeth Humes, Acadia Thielking, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Autoantibody landscapes in neurological Long COVID and post-COVID cognitive impairment show heterogeneity without a shared disease signatureDebanjana Chakravarty, Ravi Dandekar, Vishal D Lashkari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2014
Antitumor activity in RAS-driven tumors by blocking AKT and MEKAnthony W Tolcher, Khurum Khan, Michael Ong, et al.
AIDS (London, England)|March 27, 2026
Association between plasma concentrations of integrase strand transfer inhibitors and body weight gain in women living with HIVCecile D Lahiri, Adaiah P Soibi-Harry, Joffi Musonge-Effoe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 2019
High Availability of the α7-Nicotinic Acetylcholine Receptor in Brains of Individuals with Mild Cognitive Impairment: A Pilot Study Using <sup>18</sup>F-ASEM PETJennifer M Coughlin, Leah H Rubin, Yong Du, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute WorkshopPaul G Kluetz, Bindu Kanapuru, Steven Lemery, et al.
Pageof 117